Medifocus, Inc. Announces 26% Increase in Revenue in Recent Quarter and Positive Cash Flow from Operation for the Six Months Ended Sept 30, 2018

Published by admin on

Los Angeles, CA, November 27, 2018 –(– Medifocus, Inc. (OTCQB:MDFZF) and (TSX-V:MFS) (“Medifocus” or the “Company”), a biotechnology company with a portfolio of medical products encompassing thermotherapy systems for the treatment of Benign Prostatic Hyperplasia (BPH) and Breast Cancer, reported a 26% increase in revenue for the quarter ending September 30, 2018, and a 14% increase for the six months ending September 30, 2018, compared to the same periods in 2017.


Categories: Archive